Harmony Biosciences Holdings, Inc. 13D and 13G filings for Zynerba Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-08-24 5:23 pm Purchase | 2023-08-14 | 13D | Zynerba Pharmaceuticals, Inc. ZYNE | Harmony Biosciences Holdings Inc. HRMY | 7,592,498 13.130% | 7,592,498 (New Position) | Filing |